Filter
Top Products
5-1
Philips Medical Systems
5
5 Clinical and Safety Considerations
Clinical Considerations
Indications
The HeartStart FR2+ is indicated for use on victims of sudden cardiac arrest
exhibiting the following signs:
Unresponsiveness
Absence of normal breathing
The HeartStart FR2+ is intended for use by personnel who have been
trained in its operation. The user should be qualified by training in basic life
support, advanced life support, or other physician-authorized emergency
medical response.
NOTE: At the discretion of emergency care personnel, the M3860A FR2+
with ECG display enabled can also be used with the FR2+ ECG
assessment module to display the rhythm of a responsive or breathing
patient, regardless of age. There are no known contraindications to use of
the FR2+ ECG assessment module.
Contraindications
The HeartStart FR2+ is contraindicated for use (should not be used) on
patients who show either of the following signs:
Responsiveness
Presence of normal breathing
Safety Considerations
You should be aware of the safety concerns listed here when you use the
HeartStart FR2+. Read them carefully. You will also see some of these
messages in other parts of this manual. The messages are labeled Danger,
Warning, or Caution.
DANGER— immediate hazards that will result in personal injury or
death.
WARNING— conditions, hazards, or unsafe practices that can
result in serious personal injury or death.